Monte Rosa Therapeutics, Inc. (GLUE)
17.06
+0.07
(+0.41%)
USD |
NASDAQ |
Dec 10, 12:55
Monte Rosa Therapeutics Total Assets (Quarterly): 459.84M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novartis AG | 107.29B |
| AVITA Medical, Inc. | 63.73M |
| NanoVibronix, Inc. | 54.38M |
| Mirum Pharmaceuticals, Inc. | 785.12M |
| Day One Biopharmaceuticals, Inc. | 513.78M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 214.00M |
| Shareholders Equity (Quarterly) | 245.84M |
| Debt to Equity Ratio | 0.1634 |
| Current Ratio | 6.540 |
| Net Debt Paydown Yield | 0.18% |